Found: 750
Select item for more details and to access through your institution.
Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Evidence for a major role for glucagon in regulation of plasma glucose in conscious, nondiabetic, and alloxan-induced diabetic rabbits.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Glucagon immunoneutralization in diabetic rats normalizes urea synthesis and decreases nitrogen wasting.
- Published in:
- 1992
- By:
- Publication type:
- journal article
White matter integrity between left basal ganglia and left prefrontal cortex is compromised in gambling disorder.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
- Published in:
- 1998
- By:
- Publication type:
- journal article
GLP-1 tablet in type 2 diabetes in fasting and postprandial conditions.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Determinants of plasma levels of proglucagon and the metabolic impact of glucagon receptor signalling: a UK Biobank study.
- Published in:
- Diabetologia, 2024, v. 67, n. 8, p. 1602, doi. 10.1007/s00125-024-06160-1
- By:
- Publication type:
- Article
Exercise-induced increase in muscle insulin sensitivity in men is amplified when assessed using a meal test.
- Published in:
- Diabetologia, 2024, v. 67, n. 7, p. 1386, doi. 10.1007/s00125-024-06148-x
- By:
- Publication type:
- Article
The expanding incretin universe: from basic biology to clinical translation.
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1765, doi. 10.1007/s00125-023-05906-7
- By:
- Publication type:
- Article
100 years of glucagon and 100 more.
- Published in:
- Diabetologia, 2023, v. 66, n. 8, p. 1378, doi. 10.1007/s00125-023-05947-y
- By:
- Publication type:
- Article
Long-term outcomes of dietary carbohydrate restriction for HbA<sub>1c</sub> reduction in type 2 diabetes mellitus are needed. Reply to Kang J and Ma E [letter].
- Published in:
- 2022
- By:
- Publication type:
- Letter
Opposing roles of the entero-pancreatic hormone urocortin-3 in glucose metabolism in rats.
- Published in:
- Diabetologia, 2022, v. 65, n. 6, p. 1018, doi. 10.1007/s00125-022-05675-9
- By:
- Publication type:
- Article
Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial.
- Published in:
- Diabetologia, 2022, v. 65, n. 3, p. 506, doi. 10.1007/s00125-021-05628-8
- By:
- Publication type:
- Article
The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial.
- Published in:
- Diabetologia, 2021, v. 64, n. 11, p. 2425, doi. 10.1007/s00125-021-05547-8
- By:
- Publication type:
- Article
The liver–alpha cell axis associates with liver fat and insulin resistance: a validation study in women with non-steatotic liver fat levels.
- Published in:
- Diabetologia, 2021, v. 64, n. 3, p. 512, doi. 10.1007/s00125-020-05334-x
- By:
- Publication type:
- Article
Paracrine regulation of somatostatin secretion by insulin and glucagon in mouse pancreatic islets.
- Published in:
- Diabetologia, 2021, v. 64, n. 1, p. 142, doi. 10.1007/s00125-020-05288-0
- By:
- Publication type:
- Article
Effects of an intensive lifestyle intervention on the underlying mechanisms of improved glycaemic control in individuals with type 2 diabetes: a secondary analysis of a randomised clinical trial.
- Published in:
- Diabetologia, 2020, v. 63, n. 11, p. 2410, doi. 10.1007/s00125-020-05249-7
- By:
- Publication type:
- Article
The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes secondary to total pancreatectomy: a randomised, placebo-controlled, double-blinded crossover trial.
- Published in:
- Diabetologia, 2020, v. 63, n. 7, p. 1285, doi. 10.1007/s00125-020-05158-9
- By:
- Publication type:
- Article
Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality: a prospective study.
- Published in:
- Diabetologia, 2020, v. 63, n. 5, p. 1043, doi. 10.1007/s00125-020-05093-9
- By:
- Publication type:
- Article
A carbohydrate-reduced high-protein diet improves HbA<sub>1c</sub> and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial.
- Published in:
- Diabetologia, 2019, v. 62, n. 11, p. 2066, doi. 10.1007/s00125-019-4956-4
- By:
- Publication type:
- Article
No direct effect of SGLT2 activity on glucagon secretion.
- Published in:
- Diabetologia, 2019, v. 62, n. 6, p. 1011, doi. 10.1007/s00125-019-4849-6
- By:
- Publication type:
- Article
Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study.
- Published in:
- Diabetologia, 2019, v. 62, n. 4, p. 665, doi. 10.1007/s00125-018-4810-0
- By:
- Publication type:
- Article
Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study.
- Published in:
- Diabetologia, 2019, v. 62, n. 4, p. 582, doi. 10.1007/s00125-018-4807-8
- By:
- Publication type:
- Article
Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids.
- Published in:
- Diabetologia, 2018, v. 61, n. 3, p. 671, doi. 10.1007/s00125-017-4535-5
- By:
- Publication type:
- Article
GIP(3 -30)NH is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study.
- Published in:
- Diabetologia, 2018, v. 61, n. 2, p. 413, doi. 10.1007/s00125-017-4447-4
- By:
- Publication type:
- Article
Enteroendocrine K and L cells in healthy and type 2 diabetic individuals.
- Published in:
- Diabetologia, 2018, v. 61, n. 2, p. 284, doi. 10.1007/s00125-017-4450-9
- By:
- Publication type:
- Article
Counterregulatory hormone and symptom responses to hypoglycaemia in people with type 1 diabetes, insulin-treated type 2 diabetes or without diabetes: the Hypo-RESOLVE hypoglycaemic clamp study.
- Published in:
- Acta Diabetologica, 2024, v. 61, n. 5, p. 623, doi. 10.1007/s00592-024-02239-8
- By:
- Publication type:
- Article
Characterization of beta cell and incretin function in patients with MODY1 (HNF4A MODY) and MODY3 (HNF1A MODY) in a Swedish patient collection.
- Published in:
- Acta Diabetologica, 2012, v. 49, n. 5, p. 349, doi. 10.1007/s00592-011-0312-y
- By:
- Publication type:
- Article
Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists.
- Published in:
- International Journal of Clinical Practice, 2009, v. 63, n. 8, p. 1154, doi. 10.1111/j.1742-1241.2009.02086.x
- By:
- Publication type:
- Article
Altered orbitofrontal sulcogyral patterns in gambling disorder: a multicenter study.
- Published in:
- Translational Psychiatry, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41398-019-0520-8
- By:
- Publication type:
- Article
Combined local and systemic immunization is essential for durable T-cell mediated heterosubtypic immunity against influenza A virus.
- Published in:
- Scientific Reports, 2016, p. 20137, doi. 10.1038/srep20137
- By:
- Publication type:
- Article
Canagliflozin or acarbose versus placebo to ameliorate post‐bariatric hypoglycaemia – The HypoBar I randomized clinical trial protocol.
- Published in:
- Diabetic Medicine, 2024, v. 41, n. 6, p. 1, doi. 10.1111/dme.15320
- By:
- Publication type:
- Article
Effects of prebiotics on postprandial GLP‐1, GLP‐2 and glucose regulation in patients with type 2 diabetes: A randomised, double‐blind, placebo‐controlled crossover trial.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 10, p. 1, doi. 10.1111/dme.14657
- By:
- Publication type:
- Article
Pancreatic polypeptide: A potential biomarker of glucose‐dependent insulinotropic polypeptide receptor activation in vivo.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 8, p. 1, doi. 10.1111/dme.14592
- By:
- Publication type:
- Article
Effects of a whey protein pre‐meal on bone turnover in participants with and without type 2 diabetes—A post hoc analysis of a randomised, controlled, crossover trial.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 6, p. 1, doi. 10.1111/dme.14471
- By:
- Publication type:
- Article
Copeptin, a surrogate marker for arginine vasopressin secretion, is positively associated with glucagon.
- Published in:
- Diabetic Medicine, 2019, v. 36, n. 11, p. 1408, doi. 10.1111/dme.13820
- By:
- Publication type:
- Article
Nutrient re-routing and altered gut-islet cell crosstalk may explain early relief of severe postprandial hypoglycaemia after reversal of Roux-en-Y gastric bypass.
- Published in:
- Diabetic Medicine, 2017, v. 34, n. 12, p. 1783, doi. 10.1111/dme.13443
- By:
- Publication type:
- Article
Similar weight-adjusted insulin secretion and insulin sensitivity in short-duration late autoimmune diabetes of adulthood ( LADA) and Type 2 diabetes: Action LADA 8.
- Published in:
- Diabetic Medicine, 2014, v. 31, n. 8, p. 941, doi. 10.1111/dme.12434
- By:
- Publication type:
- Article
Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects.
- Published in:
- Diabetic Medicine, 2013, v. 30, n. 10, p. 1214, doi. 10.1111/dme.12231
- By:
- Publication type:
- Article
Plasma levels of glucagon like peptide-1 associate with diastolic function in elderly men.
- Published in:
- Diabetic Medicine, 2011, v. 28, n. 3, p. 301, doi. 10.1111/j.1464-5491.2010.03207.x
- By:
- Publication type:
- Article
Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes.
- Published in:
- Diabetic Medicine, 2008, v. 25, n. 11, p. 1268, doi. 10.1111/j.1464-5491.2008.02579.x
- By:
- Publication type:
- Article
Association between recent exposure to continuous glucose monitoring‐recorded hypoglycaemia and counterregulatory and symptom responses to subsequent controlled hypoglycaemia in people with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3213, doi. 10.1111/dom.15649
- By:
- Publication type:
- Article
Elucidating the glucose‐lowering effect of the bile acid sequestrant sevelamer.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 4, p. 1252, doi. 10.1111/dom.15421
- By:
- Publication type:
- Article
Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: A 52‐week randomized controlled clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 201, doi. 10.1111/dom.15306
- By:
- Publication type:
- Article